Cell proliferation as a biomarker for response to immune checkpoint inhibitors in PD-L1 negative renal cell carcinoma.
暂无分享,去创建一个
Felicia L. Lenzo | C. Morrison | Jason Zhu | Rajan T. Gupta | S. McCall | J. Conroy | S. Glenn | A. Papanicolau‐Sengos | M. Nesline | Blake Burgher | D. George | S. Pabla | Matthew K Labriola | Tian Zhang | E. Yau